Genomic Biomarkers Market by Indication and End User: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022 –

Biomarkers Market by Indication and End User : Global Industry
Perspective, Comprehensive Analysis and Forecast, 2016 – 2022”

report has been added to’s

The report covers forecast and analysis for the genomic biomarkers
market on a global and regional level. The study provides historical
data from 2014 along with a forecast from 2017 to 2022 based on revenue
(USD Billion). The study includes drivers and restraints for the genomic
biomarkers market along with the impact they have on the demand over the
forecast period. Additionally, the report includes the study of
opportunities available in the genomic biomarkers market on a global as
well as regional level.

The report provides company market share analysis in order to give a
broader overview of the key players in the market. In addition, the
report also covers key strategic developments of the market including
acquisitions mergers, new product launch, agreements, partnerships,
collaborations joint ventures, research development, regional expansion
of major participants involved in the market on the global and regional

The study provides a decisive view on the genomic biomarkers market by
segmenting the market based on the indication, end user, and regions.
All the segments have been analyzed based on present and future trends
and the market is estimated from 2017 to 2022. Based on the indication,
genomic biomarkers market has been segmented into oncology,
cardiovascular diseases, neurological diseases and others. Oncology
segment holds a maximum share of global genomic biomarkers market.

The regional segmentation includes the current and forecast demand for
North America, Europe, Asia Pacific, Latin America and the Middle East
Africa with its further bifurcation into major countries including the
U.S. Canada, Germany, France, UK, China, Japan, India, and Brazil. This
segmentation includes demand for genomic biomarkers based on individual
segment and applications in all the regions and countries.

The report also includes detailed profiles of end players such as Thermo
Fisher Scientific, Roche Diagnostics, Myriad Genetics, QIAGEN, Bio-Rad
Laboratories, US Biomarkers Inc., Almac Group and Epigenomics AG among

Market Dynamics

Market drivers

  • Increasing prevalence of cardiovascular diseases, cancer, neurological
    disorders across the globe
  • Rising need for genomic biomarker based personalized medicines

Market restraints

  • Stringent government regulations


  • Increasing adoption of personalized medicines

This report segments the global genomic biomarkers market as

Global Genomic Biomarkers Market: By Indication

  • Oncology
  • Cardiovascular diseases
  • Neurological diseases
  • Others

Global Genomic Biomarkers Market: By End User

  • Hospitals
  • Diagnostic Research Laboratories
  • Others

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Genomic Biomarkers Market Dynamics

4. Global Genomic Biomarkers Market Competitive Landscape

5. Global Genomic Biomarkers Market Indication Segment Analysis

6. Global Genomic Biomarkers Market End User Segment Analysis

7. Global Genomic biomarkers Market Regional Segment Analysis

8. Company Profiles

  • Thermo Fisher Scientific
  • Roche Diagnostics
  • Myriad Genetics
  • Bio-Rad Laboratories
  • US Biomarkers Inc.
  • Almac Group
  • Epigenomics AG

For more information about this report visit

Laura Wood, Senior Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Topics: Genomics,